معرفی
Dr. Gill Conway is a Senior Research Officer and laboratory manager in the In Vitro Toxicology Group at Swansea University Medical School. She holds a BSc in Biomolecular Science and a PhD in molecular biology and cancer therapeutics from Technological University Dublin. Her research focuses on developing predictive in vitro models for nanomaterial hazard assessment and exploring natural compounds for brain cancer treatment. She collaborates with Prof. Shareen Doak’s group and has expertise in genetic toxicology, cellular models, and nutraceuticals. Dr. Conway teaches modules on nanotoxicology and laboratory techniques in medical sciences. Her work aims to reduce reliance on animal testing and advance cancer therapeutics.
Education: BSc Biomolecular Science (TU Dublin), PhD Molecular Biology and Cancer Therapeutics (TU Dublin). Previous positions include work at the National Institute for Bioprocessing Research and Training (NIBRT), Ireland.
Research Interests: 3D liver models, nanomaterial genotoxicity, glioblastoma treatment, natural bioactives, cold atmospheric plasma applications, and exercise-conditioned serum effects. She has contributed to over 20 peer-reviewed articles and book chapters since 2016.
Teaching: Module leader for 'Nano(geno)toxicology' (PM-M28) and 'Laboratory Measurement Techniques for Medical Sciences' (PMLM22).
